Management of postpolio syndrome

Mayo Clinic Proceedings

Volumn 72, Issue 7, 1997, Pages 627-638

  Thorsteinsson, Gudni ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARNITINE; CILIARY NEUROTROPHIC FACTOR; LEVACECARNINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PRASTERONE; PYRIDOSTIGMINE; SELEGILINE;

ARTICLE; COLD TOLERANCE; COMORBIDITY; DIET THERAPY; DYSPHAGIA; DYSPNEA; DYSURIA; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; HEADACHE; HOT FLUSH; HUMAN; INSOMNIA; MUSCLE FATIGUE; MUSCLE TWITCH; MUSCLE WEAKNESS; MYALGIA; OBESITY; POLIOMYELITIS; POSTPOLIOMYELITIS SYNDROME; SCOLIOSIS; WHEELCHAIR;

EID: 0030746507     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)63568-4     Document Type: Article

References (67)

1. Dalakas MC. The post-polio syndrome as an evolved clinical entity: definition and clinical description. Ann N Y Acad Sei 1995;753:68-80
2. Raymond M. Paralysie essentielle de l'enfance, atrophie musculaire consécutive. C Rendus Heb Seances Mem Soc Biol 1875;27:158-160
3. Mulder DW, Rosenbaum RA, Layton DD Jr. Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis? Mayo Clin Proc 1972;47:756-761
4. Dalakas MC. Post-polio syndrome 12 years later: how it all started. Ann N Y Acad Sei 1995;753:11-18
5. Halstead LS, Rossi CD. New problems in old polio patients: results of a survey of 539 polio survivors. Orthopedics 1985;8:845-850
6. Mulder DW. Clinical observations on acute poliomyelitis. Ann N Y Acad Sei 1995;753:1-10
7. Salk J. One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine. Rev Infect Dis 1984;6(Suppl 2):S444-S450
8. Robbins FC. Eradication of polio in the Americas. JAMA 1993;270:1857-1859
9. Centers for Disease Control and Prevention. National poliomyelitis immunization days-People's Republic of China, 1993. JAMA 1993;270:2537;2541
10. World Health Organization, Geneva. Expanded programme on immunization-progress towards poliomyelitis eradication, 1994. Wkly Epidemiol Rec 1995:70:97-104
11. lila I, Leon-Monzon M, Agboatwalla M, Dure-Samin A, Dalakas MC. Role of the muscle in acute poliomyelitis infection. Ann N Y Acad Sei 1995;753:58-67
12. Leon-Monzon ME, Ilia I, Dalakas MC. Expression of poliovirus receptor in human spinal cord and muscle. Ann N Y Acad Sei 1995;753:48-57
13. Gromeier M, Lu HH, Bernhardt G, Harber JJ, Bibb JA, Wimmer E. The human poliovirus receptor: receptor-virus interaction and parameters of disease specificity. Ann N Y Acad Sei 1995;753:19-36
14. Bruno RL, Frick NM, Cohen J. Polioencephalitis, stress, and the etiology of post-polio sequelae. Orthopedics 1991; 14:1269-1276
15. Bruno RL, Cohen JM, Galski T, Frick NM. The neuroanatomy of post-polio fatigue. Arch Phys Med Rehabil 1994;75:498-504
16. Bruno RL, Sapolsky R, Zimmerman JR, Frick NM. Pathophysiology of a central cause of post-polio fatigue. Ann N Y Acad Sei 1995;753:257-275
17. Dalakas MC. Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations. Ann N Y Acad Sei 1995; 753:167-185
18. Windebank AJ, Litchy WJ, Daube JR, Kurland LT, Codd MB, Iverson R. Late effects of paralytic poliomyelitis in Olmsted County, Minnesota. Neurology 1991 ;41:501 507
19. Marwick C. Polio vaccine schedule will change, but when? JAMA 1996:275:827
20. Marwick C. Will US polio immunization rely on IPV or OPV? JAMA 1995;274:12-13
21. Halstead LS, Rossi CD. Post-polio syndrome: clinical experience with 132 consecutive outpatients. Birth Defects 1987;23:13-26
22. Agre JC, Rodriguez AA, Sperling KB. Symptoms and clinical impressions of patients seen in a postpolio clinic. Arch Phys Med Rehabil 1989;70:367-370
23. L0nnberg F. Late onset polio sequelae in Denmark: presentation and results of a nation-wide survey of 3,607 polio survivors. Scand J Rehabil Med Suppl 1993;28:7-15
24. Agre JC. The role of exercise in the patient with post-polio syndrome. Ann N Y Acad Sei 1995;753:321-334
25. Halstead LS. Assessment and differential diagnosis for post-polio syndrome. Orthopedics 1991; 14:1209-1217
26. Waring WP, McLaurin TM. Correlation of creatine kinase and gait measurement in the postpolio population: a corrected version. Arch Phys Med Rehabil 1992;73:447450
27. Wiechers D. Electrophysiology of acute polio revisited: utilizing newer EMG techniques in vaccine-associated disease. Ann N Y Acad Sei 1995;753:111-119
28. Bruno RL, Galski T, DeLuca J. The neuropsychology of post-polio fatigue. Arch Phys Med Rehabil 1993;74:10611065
29. Halstead LS. The lessons and legacies of polio. In: Halstead LS, Grimby G, editors. Post-Polio Syndrome. Philadelphia: Hanley & Belfus; 1995. pp 199-214
30. Halstead LS, Gawne AC, Pham BT. National Rehabilitation Hospital Limb Classification for exercise, research, and clinical trials in post-polio patients. Ann N Y Acad Sei 1995;753:343-353
31. Gawne AC. Strategies for exercise prescription in post-polio patients. In: Halstead LS, Grimby G, editors. Post-Polio Syndrome. Philadelphia: Hanley & Belfus; 1995. pp HI164
32. Kaminski HJ, Tresser N, Hogan RE, Martin E. Spinal cord histopathology in long-term survivors of poliomyelitis. Muscle Nerve 1995;18:1208-1209
33. Dinsmore ST, Dalakas MC. Are there immunopathologic changes in patients with post-polio syndrome? In: Halstead LS, Grimby G, editors. Post-Polio Syndrome. Philadelphia: Hanley & Belfus; 1995. pp 1-14
34. Grimby G, Stâlberg E. Muscle function, muscle structure, and electrophysiology in a dynamic perspective in late polio. In: Halstead LS, Grimby G, editors. Post-Polio Syndrome. Philadephia: Hanley & Belfus; 1995. pp 15-24
35. Dinsmore S, Dambrosia J, Dalakas MC. A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome. Ann N Y Acad Sei 1995;753:303-313
36. Trojan DA, Cashman NR, Shapiro S, Tansey CM, Esdaile JM. Predictive factors for post-poliomyelitis syndrome. Arch Phys Med Rehabil 1994;75:770-777
37. Daube JR, Windebank AJ, Litchy WJ. Electrophysiologic changes in neuromuscular function over five years in polio survivors. Ann N Y Acad Sei 1995;753:120-128
38. Windebank AJ, Litchy WJ, Daube JR, Iverson RA. Lack of progression of neurologic deficit in survivors of paralytic polio: a 5-year prospective population-based study. Neurology 1996;46:80-84
39. Scheer J, Luborsky ML. The cultural context of polio biographies. Orthopedics 1991; 14:1173-1181
40. Stein DP, Dambrosia JM, Dalakas MC. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. Ann N Y Acad Sei 1995;753:296-302
41. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995;274:961-967
42. Cashman NR, Trojan DA. Correlation of electrophysiology with pathology, pathogenesis, and anticholinesterase therapy in post-polio syndrome. Ann N Y Acad Sei 1995;753:138150
43. Trojan DA, Cashman NR. Anticholinesterases in postpoliomyelitis syndrome. Ann N Y Acad Sei 1995;753:285295
44. Maselli RA, Wollmann R, Roos R. Function and ultrastructure of the neuromuscular junction in post-polio syndrome. Ann N Y Acad Sei 1995;753:129-137
45. Young GR. Energy conservation, occupational therapy, and the treatment of post-polio sequelae. Orthopedics 1991; 14:1233-1239
46. Schwartz CE, Coulthardmorris L, Zeng Q. Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 1996;77:165-170
47. Peach PE, Olejnik S. Effect of treatment and noncompliance on post-polio sequelae. Orthopedics 1991;14:1199-1203
48. Seizert BP, Speier JL, Canine K. Pyridostigmine effect on strength, endurance and fatigue in post-polio patients [abstract]. Arch Phys Med Rehabil 1994;75:1049
49. Sunnerhagen KS, Bengtsson BA, Lundberg PA, Landin K, Lindstedt G, Grimby G. Normal concentrations of serum insulin-like growth factor-1 in late polio. Arch Phys Med Rehabil 1995;76:732-735
50. Grimby G, Einarsson G. Post-polio management. Crit Rev Phys Rehabil Med 1991;2:189-200
51. Borg K, Borg J, Edstrom L, Grimby L. Effects of excessive use of remaining muscle fibers in prior polio and LV lesion. Muscle Nerve 1988;! 1:1219-1230
52. Borg K, Edström L. Muscle fiber morphology in post-polio patients. In: Halstead LS, Grimby G, editors. Post-Polio Syndrome. Philadelphia: Hanley & Belfus; 1995. pp 2533
53. Einarsson G. Muscle conditioning in late poliomyelitis. Arch Phys Med Rehabil 1991 ;72:11-14
54. Feldman RM, Soskolne CL. The use of nonfatiguing strengthening exercises in post-polio syndrome. Birth Defects 1987;23(No. 4):335-341
55. Fillyaw MJ, Badger GJ, Goodwin GD, Bradley WG, Fries TJ, Shukla A. The effects of long-term non-fatiguing resistance exercise in subjects with post-polio syndrome. Orthopedics 1991;14:1253-1256
56. Grimby G, Einarsson G, Hedberg M, Aniansson A. Muscle adaptive changes in post-polio subjects. Scand J Rehabil Med 1989;21:19-26
57. Trojan DA, Cashman NR. Fibromyalgia is common in a postpoliomyelitis clinic. Arch Neurol 1995;52:620624
58. Kottke FJ. Therapeutic exercises to maintain mobility. In: Kottke FJ, Lehmann JF, editors. Krusen's Handbook of Physical Medicine and Rehabilitation. Philadelphia: Saunders; 1990. pp 436-451
59. Dean E, Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics 1991; 14:1243-1246
60. Owen RR, Jones D. Polio residuals clinic: conditioning exercise program. Orthopedics 1985;8:882-883
61. Conrady LJ, Wish JR, Agre JC, Rodriguez AA, Sperling KB. Psychologic characteristics of polio survivors: a preliminary report. Arch Phys Med Rehabil 1989;70:458-463
62. Grafman J, Clark K, Richardson D, Dinsmore S, Stein D, Dalakas MC. Neuropsychology of post-polio syndrome. AnnNYAcadSci 1995;753:103-110
63. Täte DG, Forchheimer M, Kirsch N, Maynard F, Roller A. Prevalence and associated features of depression and psychological distress in polio survivors. Arch Phys Med Rehabil 1993;74:1056-1060
64. Bruno RL, Frick NM. The psychology of polio as prelude to post-polio sequelae: behavior modification and psychotherapy. Orthopedics 1991;l4:l 185-1193
65. Freidenberg DL, Freeman D, Huber SJ, Perry J, Fischer A, Van Gorp WG, et al. Cited by Grafman and associates.62
66. Bach JR. Management of post-polio respiratory sequelae. AnnNYAcadSci 1995;753:96-102
67. Sonies BC, Dalakas MC. Progression of oral-motor and swallowing symptoms in the post-polio syndrome. Ann N Y AcadSci 1995;753:87-95